• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估在高传播性变异株时代在中国维持新冠病毒局部控制的可行性。

Assessing the feasibility of sustaining SARS-CoV-2 local containment in China in the era of highly transmissible variants.

作者信息

Wang Yan, Sun Kaiyuan, Feng Zhaomin, Yi Lan, Wu Yanpeng, Liu Hengcong, Wang Quanyi, Ajelli Marco, Viboud Cécile, Yu Hongjie

机构信息

School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China.

Division of International Epidemiology and Population Studies, Fogarty International Center, National Institutes of Health, Bethesda, MD, USA.

出版信息

medRxiv. 2022 Jun 6:2022.05.07.22274792. doi: 10.1101/2022.05.07.22274792.

DOI:10.1101/2022.05.07.22274792
PMID:35611330
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9128785/
Abstract

We developed a spatially structured, fully stochastic, individual-based SARS-CoV-2 transmission model to evaluate the feasibility of sustaining SARS-CoV-2 local containment in mainland China considering currently dominant Omicron variants, China's current immunization level, and non-pharmaceutical interventions (NPIs). We also built a statistical model to estimate the overall disease burden under various hypothetical mitigation scenarios. We found that due to high transmissibility, neither Omicron BA.1 or BA.2 could be contained by China's pre-Omicron NPI strategies which were successful prior to the emergence of the Omicron variants. However, increased intervention intensity, such as enhanced population mobility restrictions and multi-round mass testing, could lead to containment success. We estimated that an acute Omicron epidemic wave in mainland China would result in significant number of deaths if China were to reopen under current vaccine coverage with no antiviral uptake, while increasing vaccination coverage and antiviral uptake could substantially reduce the disease burden. As China's current vaccination has yet to reach high coverage in older populations, NPIs remain essential tools to maintain low levels of infection while building up protective population immunity, ensuring a smooth transition out of the pandemic phase while minimizing the overall disease burden.

摘要

我们构建了一个空间结构化、完全随机、基于个体的新冠病毒传播模型,以评估在中国内地维持新冠病毒局部控制的可行性,其中考虑了当前占主导的奥密克戎变种、中国目前的免疫水平以及非药物干预措施(NPIs)。我们还建立了一个统计模型,以估计各种假设的缓解情景下的总体疾病负担。我们发现,由于奥密克戎的高传播性,中国在奥密克戎变种出现之前成功实施的、针对奥密克戎出现前情况的非药物干预策略,无法控制奥密克戎BA.1或BA.2毒株。然而,提高干预强度,如加强人口流动限制和多轮大规模检测,可能会导致控制成功。我们估计,如果中国在目前的疫苗接种覆盖率且无抗病毒药物使用的情况下重新开放,中国大陆的奥密克戎急性疫情波将导致大量死亡,而提高疫苗接种覆盖率和抗病毒药物使用率可以大幅减轻疾病负担。由于中国目前在老年人群中的疫苗接种尚未达到高覆盖率,非药物干预措施仍然是维持低感染水平的重要工具,同时建立人群保护性免疫,确保平稳过渡到疫情结束阶段,同时将总体疾病负担降至最低。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a361/9176322/3c3adc12fbf1/nihpp-2022.05.07.22274792v2-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a361/9176322/f117912189c7/nihpp-2022.05.07.22274792v2-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a361/9176322/f810ad194e01/nihpp-2022.05.07.22274792v2-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a361/9176322/7d44d370e09d/nihpp-2022.05.07.22274792v2-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a361/9176322/3c3adc12fbf1/nihpp-2022.05.07.22274792v2-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a361/9176322/f117912189c7/nihpp-2022.05.07.22274792v2-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a361/9176322/f810ad194e01/nihpp-2022.05.07.22274792v2-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a361/9176322/7d44d370e09d/nihpp-2022.05.07.22274792v2-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a361/9176322/3c3adc12fbf1/nihpp-2022.05.07.22274792v2-f0004.jpg

相似文献

1
Assessing the feasibility of sustaining SARS-CoV-2 local containment in China in the era of highly transmissible variants.评估在高传播性变异株时代在中国维持新冠病毒局部控制的可行性。
medRxiv. 2022 Jun 6:2022.05.07.22274792. doi: 10.1101/2022.05.07.22274792.
2
Assessing the feasibility of sustaining SARS-CoV-2 local containment in China in the era of highly transmissible variants.评估在高传播性变异株流行时期中国维持 SARS-CoV-2 局部控制的可行性。
BMC Med. 2022 Nov 15;20(1):442. doi: 10.1186/s12916-022-02640-6.
3
Modeling transmission of SARS-CoV-2 Omicron in China.模拟 SARS-CoV-2 奥密克戎在中国的传播。
Nat Med. 2022 Jul;28(7):1468-1475. doi: 10.1038/s41591-022-01855-7. Epub 2022 May 10.
4
COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant, and implications for vaccination.印度的新冠疫情动态、严重急性呼吸综合征冠状病毒2(SARS-CoV-2)德尔塔变异株及其对疫苗接种的影响
medRxiv. 2021 Nov 22:2021.06.21.21259268. doi: 10.1101/2021.06.21.21259268.
5
SARS-CoV-2 containment was achievable during the early stage of the pandemic: a retrospective modelling study of the Xinfadi outbreak in Beijing.在疫情早期阶段,新冠病毒是可以得到控制的:对北京新发地疫情的回顾性建模研究
medRxiv. 2022 Sep 14:2022.09.12.22279850. doi: 10.1101/2022.09.12.22279850.
6
Impact of vaccination and non-pharmaceutical interventions on SARS-CoV-2 dynamics in Switzerland.接种疫苗和非药物干预措施对瑞士 SARS-CoV-2 动力学的影响。
Epidemics. 2022 Mar;38:100535. doi: 10.1016/j.epidem.2021.100535. Epub 2021 Dec 14.
7
The impact of age structure and vaccine prioritization on COVID-19 in West Africa.年龄结构和疫苗优先级对西非地区新冠肺炎的影响。
Infect Dis Model. 2022 Dec;7(4):709-727. doi: 10.1016/j.idm.2022.08.006. Epub 2022 Sep 8.
8
Threshold conditions for curbing COVID-19 with a dynamic zero-case policy derived from 101 outbreaks in China.运用中国 101 起疫情数据推算出的动态清零政策遏制新冠疫情的阈值条件。
BMC Public Health. 2023 Jun 6;23(1):1084. doi: 10.1186/s12889-023-16009-8.
9
Vaccination as an alternative to non-drug interventions to prevent local resurgence of COVID-19.疫苗接种作为非药物干预措施的替代方案,以预防 COVID-19 在当地的再次爆发。
Infect Dis Poverty. 2022 Mar 26;11(1):36. doi: 10.1186/s40249-022-00960-6.
10
[Considerations on vaccines and immunization against COVID-19 for epidemic control in China].关于中国新冠疫情防控中新冠疫苗及免疫接种的思考
Zhonghua Yu Fang Yi Xue Za Zhi. 2021 Dec 6;55(12):1371-1376. doi: 10.3760/cma.j.cn112150-20211015-00951.

本文引用的文献

1
Modeling transmission of SARS-CoV-2 Omicron in China.模拟 SARS-CoV-2 奥密克戎在中国的传播。
Nat Med. 2022 Jul;28(7):1468-1475. doi: 10.1038/s41591-022-01855-7. Epub 2022 May 10.
2
Rapid and parallel adaptive mutations in spike S1 drive clade success in SARS-CoV-2.刺突蛋白 S1 中的快速且平行的适应性突变驱动 SARS-CoV-2 谱系成功。
Cell Host Microbe. 2022 Apr 13;30(4):545-555.e4. doi: 10.1016/j.chom.2022.03.018. Epub 2022 Mar 22.
3
Transmission of SARS-CoV-2 delta variant (AY.127) from pet hamsters to humans, leading to onward human-to-human transmission: a case study.
新冠病毒德尔塔变异株(AY.127)从宠物仓鼠传播给人类,并导致人际传播:一项病例研究。
Lancet. 2022 Mar 12;399(10329):1070-1078. doi: 10.1016/S0140-6736(22)00326-9.
4
Transmission dynamics and epidemiological characteristics of SARS-CoV-2 Delta variant infections in Guangdong, China, May to June 2021.2021 年 5 月至 6 月期间中国广东地区 SARS-CoV-2 Delta 变异株感染的传播动态和流行病学特征。
Euro Surveill. 2022 Mar;27(10). doi: 10.2807/1560-7917.ES.2022.27.10.2100815.
5
Generation time of the alpha and delta SARS-CoV-2 variants: an epidemiological analysis.阿尔法和德尔塔 SARS-CoV-2 变异株的生成时间:一项流行病学分析。
Lancet Infect Dis. 2022 May;22(5):603-610. doi: 10.1016/S1473-3099(22)00001-9. Epub 2022 Feb 14.
6
Prediction of long-term kinetics of vaccine-elicited neutralizing antibody and time-varying vaccine-specific efficacy against the SARS-CoV-2 Delta variant by clinical endpoint.通过临床终点预测疫苗诱导的中和抗体的长期动力学和针对 SARS-CoV-2 Delta 变异株的时变疫苗特异性疗效。
BMC Med. 2022 Jan 28;20(1):36. doi: 10.1186/s12916-022-02249-9.
7
Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022.在德尔塔和奥密克戎变异株流行期间,mRNA 疫苗加强针在成年人中的 COVID-19 相关急诊和紧急护理就诊和住院方面的效果 - VISION 网络,10 个州,2021 年 8 月至 2022 年 1 月。
MMWR Morb Mortal Wkly Rep. 2022 Jan 21;71(4):139-145. doi: 10.15585/mmwr.mm7104e3.
8
Neutralizing antibodies against the SARS-CoV-2 Delta and Omicron variants following heterologous CoronaVac plus BNT162b2 booster vaccination.接种异源科兴疫苗加辉瑞-BioNTech 加强针后对 SARS-CoV-2 德尔塔和奥密克戎变异株的中和抗体。
Nat Med. 2022 Mar;28(3):481-485. doi: 10.1038/s41591-022-01705-6. Epub 2022 Jan 20.
9
SARS-CoV-2 infection in free-ranging white-tailed deer.SARS-CoV-2 感染自由放养的白尾鹿。
Nature. 2022 Feb;602(7897):481-486. doi: 10.1038/s41586-021-04353-x. Epub 2021 Dec 23.
10
Rapid and sustained containment of covid-19 is achievable and worthwhile: implications for pandemic response.快速和持续控制新冠疫情是可行且值得的:对大流行应对措施的影响。
BMJ. 2021 Dec 1;375:e066169. doi: 10.1136/BMJ-2021-066169.